Angela Walsh
Chief Financial Officer · Dogwood Therapeutics, Inc.
Individual
- 2025
- Mar 6, 2026
- 3
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Angela Walsh's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- CP Circle ML Holdco GP, LLC - $1.07B in MDLN purchases and sales in the last 12 months
- TC Group Cayman Investment Holdings, L.P. - $1.07B in MDLN purchases and sales in the last 12 months
- Martine A. Rothblatt - $798.23M in UTHR purchases and sales in the last 12 months
- TPG GP A, LLC - $742.97M in LFST purchases and sales in the last 12 months
- GTCR INVESTMENT XI LLC - $639.50M in SHC purchases and sales in the last 12 months
- Keith A. Meister - $591.13M in ILMN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Angela Walsh?
Angela Walsh is a corporate insider, tracked as Chief Financial Officer of Dogwood Therapeutics, Inc. (DWTX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Angela Walsh last file a Form 4?
The most recent primary Form 4 on record is dated 6 March 2026, one of 3 filings going back to 2025.